Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Translation in Brief

Diseased oligodendrocytes

Why oligodendrocytes could be new disease targets, not passive victims, in MS

December 11, 2018 5:40 PM UTC

A Karolinska Institute team has identified subsets of oligodendrocyte lineage cells that may trigger T cell immunity in multiple sclerosis and proposed the cells as new disease targets. The findings suggest the myelin-producing cells are not passive victims of the immune system, but instead actively modulate it in MS.

In the study, published in Nature Medicine in November, the researchers used single-cell RNA sequencing and clustering analysis to identify populations of oligodendrocytes and oligodendrocyte precursor cells (OPCs) in the spinal cords of the experimental autoimmune encephalomyelitis (EAE) mouse model of MS that were absent from the spinal cords of normal mice. The two oligodendrocyte populations from the MS mice expressed high levels of major histocompatibility complex class I (MHC I) and MHCII genes...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article